ISHLT Honors Innovation in Heart and Lung Disease Research by All Members of the Care Team

Published 12 August 2021
  • Grants, Awards & Scholarships
  • Press Release
  • Scientific Abstract Award

Download Press Release (PDF)

Society recognizes ISHLT2021 abstract presentations to elevate professional specialties and encourage a multidisciplinary ISHLT

ADDISON, Texas – 12 August, 2021 – ISHLT has announced the winners of the new ISHLT Professional Community Awards for Excellence. These awards recognize professional excellence in each of the Professional Communities represented within ISHLT, support the component groups that enable ISHLT’s interdisciplinary approach, and elevate and empower all Professional Communities equally.

To accommodate the virtual nature of the ISHLT’s 2021 Annual Meeting, which drew more than 3,000 attendees, the Society developed a virtual judging protocol that expanded the number of judges who could participate and increased the total amount of time they could spend evaluating each presentation.

These winners were drawn from eligible abstracts accepted for presentation at the 41st Annual ISHLT Meeting & Scientific Sessions. The full abstracts were published in a special supplement to the Journal of Heart and Lung Transplantation’s April 2021 issue. These award winners will also be featured in ISHLTv webinars this October.

Headshot of Jamel Ortoleva
ANESTHESIOLOGY AND CRITICAL CARE PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Jamel Ortoleva, MD
Tufts Medical Center
Boston, MA USA
Presentation: Effect of the New Donor Heart Allocation System on Waitlist Mortality Among All Candidates Listed With Mechanical Circulatory Support

Headshot of Yael Peled
CARDIOLOGY PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Yael Peled, MD
Sheba Medical Center
Kiryat Uno, Israel
Presentation: CA125 Predicts Right Heart Hemodynamic and Function and Identifies Distinct Congestion Phenotypes: Guidance for Therapy

Headshot of Yoshito Yamada
CARDIOTHORACIC SURGERY PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Yoshito Yamada, MD, PhD
Kyoto University Hospital
Kyoto, Japan
Presentation: CD26+ Epithelial Cell Clusters as a Novel Biomarker and Therapeutic Target in Chronic Lung Allograft Dysfunction

Headshot of Ann Woolley
INFECTIOUS DISEASES PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Ann Woolley, MD, MPH
Brigham and Women’s Hospital
Boston, MA USA
Presentation: Long-term Outcomes In Heart And Lung Transplants From HCV-Viremic Donors To Uninfected Recipients: The Donate HCV Trial

Headshot of Thomas Schlöglhofer
NURSING AND ALLIED HEALTH PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Thomas Schloeglhofer, MSc
Medical University of Vienna
Vienna, Austria
Presentation: Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study

Headshot of Kyle Hope
PEDIATRICS PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Kyle Hope, MD, MS
Texas Children’s Hospital
Houston, TX USA
Presentation: Atypical Infiltrates On Endomyocardial Biopsy Are Associated With Adverse Outcomes In Pediatric Heart Transplantation

Headshot of Lisa Peters
PHARMACY PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Lisa Peters, PharmD, BCPS
MedStar Washington Hospital Center
Washington, DC USA
Presentation: Impact Of Using A Low Anti-Xa Target Heparin Protocol On Hemocompatibility-related Outcomes After Implantation Of A Heartmate 3 Device

Headshot of Joshua Diamond
PULMONOLOGY PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Joshua Diamond, MD
University of Pennsylvania
Philadelphia, PA USA
Presentation: mHealth to Improve Emergent Frailty After Lung Transplantation

Headshot of Kevin Zhang
RESEARCH AND IMMUNOLOGY PROFESSIONAL COMMUNITY AWARD FOR EXCELLENCE

Kevin Zhang, BHSc
University of Toronto
Toronto, ON Canada
Presentation: The Diagnostic and Prognostic Value of Bronchial Wash for Evaluating Microaspiration in Lung Transplant Recipients

About ISHLT
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.